These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 4308016)
61. [Diseases of the motoric end plate including myasthenia gravis]. Struppler A Wien Klin Wochenschr; 1967 Aug; 79(33):620-2. PubMed ID: 4298887 [No Abstract] [Full Text] [Related]
62. Studies on the trophic influence of nerve on skeletal muscle. Hofmann WW; Thesleff S Eur J Pharmacol; 1972 Dec; 20(3):256-60. PubMed ID: 4118681 [No Abstract] [Full Text] [Related]
63. Acetylcholinesterase activity of skeletal muscle in a non-immunogenic model for myasthenia gravis in rats. Van Kempen GT; Trip SA; Molenaar PC J Neural Transm (Vienna); 1999; 106(5-6):423-31. PubMed ID: 10443548 [TBL] [Abstract][Full Text] [Related]
64. Surplus acetylcholine and acetylcholine release in the rat diaphragm. Molenaar PC; Oen BS; Polak RL; van der Laaken AL J Physiol; 1987 Apr; 385():147-67. PubMed ID: 3498823 [TBL] [Abstract][Full Text] [Related]
65. Thymopoietin and myasthenia gravis: neostigmine-responsive neuromuscular block produced in mice by a synthetic peptide fragment of thymopoietin. Goldstein G; Schlesinger DH Lancet; 1975 Aug; 2(7928):256-9. PubMed ID: 49801 [TBL] [Abstract][Full Text] [Related]
66. Post-tetanic and drug-induced repetitive firing in the soleus muscle of the cat. Bowman WC; Goldberg AA; Raper C Br J Pharmacol; 1969 Jan; 35(1):62-78. PubMed ID: 4302727 [TBL] [Abstract][Full Text] [Related]
67. Incorporation of synaptotagmin II to the axolemma of botulinum type-A poisoned mouse motor endings during enhanced quantal acetylcholine release. Angaut-Petit D; Molgó J; Faille L; Juzans P; Takahashi M Brain Res; 1998 Jun; 797(2):357-60. PubMed ID: 9666170 [TBL] [Abstract][Full Text] [Related]
68. Diffusion of acetylcholine in the synaptic cleft of normal and myasthenia gravis human endplates. Cull-Candy SG; Miledi R; Uchitel OD Nature; 1980 Jul; 286(5772):500-2. PubMed ID: 7402330 [No Abstract] [Full Text] [Related]
69. The motor end plate in myasthenia gravis and in experimental autoimmune myasthenia gravis. A quantitative ultrastructural study. Engel AG; Tsujihata M; Lindstrom JM; Lennon VA Ann N Y Acad Sci; 1976; 274():60-79. PubMed ID: 1066997 [TBL] [Abstract][Full Text] [Related]
70. Effects of electrical stimulation on acetylcholine levels in central cholinergic nerve terminals. Rommelspacher H; Kuhar MJ Brain Res; 1974 Dec; 81(2):243-51. PubMed ID: 4373127 [No Abstract] [Full Text] [Related]
71. Recycling of acetylcholine following impulse transmission in rat muscle revealed in the presence of neostigmine. Uramoto I; Miyamoto K; Watanabe K; Totsuka T Clin Exp Pharmacol Physiol; 1998 Jan; 25(1):44-9. PubMed ID: 9493558 [TBL] [Abstract][Full Text] [Related]
72. Motor nerve sprouting and acetylcholine receptors. Pestronk A; Drachman DB Science; 1978 Mar; 199(4334):1223-5. PubMed ID: 204007 [TBL] [Abstract][Full Text] [Related]
73. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction. Molgó J; del Pozo E; Baños JE; Angaut-Petit D Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201 [TBL] [Abstract][Full Text] [Related]
75. [Dependence of the effects of neostigmine, nivaline and paraoxon on the stimulation frequency]. Walther H Acta Biol Med Ger; 1969; 22(5):767-78. PubMed ID: 5372104 [No Abstract] [Full Text] [Related]
76. In vitro neuromuscular effects of delta9-trans-tetrahydrocannabinol (THC). Kayaalp SO; Kaymakçalan S; Verimer T; Ilhan M; Onur R Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):67-75. PubMed ID: 4375439 [No Abstract] [Full Text] [Related]
77. The generation of nerve and muscle repetivie activity in the rat phrenic nerve-diaphragm preparation following inhibition of cholinesterase by ecothiopate. Morrison JD Br J Pharmacol; 1977 May; 60(1):45-53. PubMed ID: 195659 [TBL] [Abstract][Full Text] [Related]
78. Enhanced spontaneous transmitter release at murine motor nerve terminals with cyclosporine. Lin MJ; Lin-Shiau SY Neuropharmacology; 1999 Jan; 38(1):195-8. PubMed ID: 10193910 [TBL] [Abstract][Full Text] [Related]
79. Effect of antibodies against skeletal muscle constituents on muscle function in rats. Namba T; Grob D Rev Can Biol; 1969 Mar; 28(1):9-18. PubMed ID: 5770982 [No Abstract] [Full Text] [Related]
80. Newer drugs for myasthenia gravis; a microphysiologic study of effects. Hofmann WW J Pharmacol Exp Ther; 1968 Apr; 160(2):349-59. PubMed ID: 5647303 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]